BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Colitis News and Headlines
Colitis News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Colitis news alerts.
Site Map > Biotechnology News > Health News > Colitis
.

Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
DiGiTAL50:  similar ...
Interferon-ribavirin-associated ischemic colitis
Facts & Comparisons:  similar ...
Ezetimibe-associated thrombocytopenia;
Facts & Comparisons:  similar ...
Ventricular arrhymia during sodium bicarbonate infusion;
Facts & Comparisons:  similar ...
Baboon syndrome induced by cetuximab;
Facts & Comparisons:  similar ...
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
Therapeutics Daily:  similar ...
Pluristem to be Featured on RedChip's Real Radio(TM) Show Broadcast
Yahoo!:  similar ...
Pluristem to be Featured on RedChip's Real Radio(TM) Show Broadcast
Genetic Engineering News:  similar ...
The 10th Annual C21 BioVentures Presenter Profiles
Genetic Engineering News:  similar ...
Pluristem Announces Removal of Restrictive Legends on Shares of Restricted Common Stock According to May 2007
Yahoo!:  similar ...
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
PR Newswire:  similar ...
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
KOTA Territory News:  similar ...
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
Macro World Investor:  similar ...
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008
Yahoo! Canada:  similar ...
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive
FinanzNachrichten.de:  similar ...
Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119,
PR Newswire via MSN Money:  similar ...
Medarex Announces Initiation Of Phase 2 Clinical Trials For The Treatment Of Ulcerative Colitis And Rheumatoid
Medical News Today:  similar ...
JournalScan
British Journal of the Gut:  similar ...
Hollis-Eden Pharmaceuticals Provides Update on Clinical Development Programs; Announces First Quarter 2008 Fin
Yahoo!:  similar ...
Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid
Pharma Live:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.